Clinical Trials Directory

Trials / Completed

CompletedNCT03992040

Assessment of Medico-economic Relevance of Care of Polypathological Patients by a Reinforced Home Nursing Care Services (SSIAD) Device

Assessment of Medico-economic Relevance of Care of Polypathological Patients by a Reinforced Home Nursing Care Services (SSIAD)Device

Status
Completed
Phase
Study type
Observational
Enrollment
677 (actual)
Sponsor
Gérond'if · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The main purpose is to study, in comparison to classic Home Nursing Care Services (SSIAD), the effect of reinforced Home Nursing Care Services (SSIAD) on the occurrence of hospitalizations

Detailed description

It's a non-interventional, multi-centred, controlled study. Inclusions will start with patients benefit from a so-called "reinforced" bed in the experimental Home Nursing Care Services (SSIAD), that is, with a score between 11 and 21 on the regional public health authorities (ARS) score. Patients from the classic Home Nursing Care Services SSIAD (control arm) will be inclused on a matching mode to the individual clinical profiles of patients recruited into the reinforced Home Nursing Care Services (SSIAD). Matching will be based on age, sex, and comorbidity score (Charlson scale). Screening for matching will be done by a geriatric physician appointed by the sponsor. Once screened in, patients will be proposed the study by the Home Nursing Care Services SSIAD lead investigator who provides home care. Patients in the control arm will also express no opposition. For each patient accepting the study, their family caregiver - if there is one - will also be proposed the study. Various data: Prescription medicinal, reason and duration of hospitalization, number and reason for emergency department presentations, independence and dependency scores and other scales will be collected retrospectively, at inlcusion (J0) , then monthly (M1 to M12).

Conditions

Timeline

Start date
2019-07-25
Primary completion
2022-06-30
Completion
2023-06-30
First posted
2019-06-19
Last updated
2024-04-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03992040. Inclusion in this directory is not an endorsement.